ホームページへ

Bone Marrow Transplant for Pediatric Hodgkin Lymphoma at Sheba Hospital- JCI accreditated and Top-10 Hospitals 2025 by Newsweek

イスラエル ラマト・ガン
Map
シェバ医療センター
クリニックを見る
5
医師 5.0
スタッフ 5.0
施設 5.0
言語サポート 5.0
サポート 5.0
強く推奨
98%のクライアントがこのクリニックを推奨
4 患者
昨年このクリニックでの治療を選択されました

このパッケージに含まれるもの

医療処置
  • 生化学的血液検査
  • 血液内科相談
  • センチネルリンパ節生検
  • オンコヘマトロジー相談
  • 骨髄穿刺検査および細胞遺伝学分析
  • 骨髄移植術
  • 栄養士による1日3食
  • 24時間看護サービス
  • 心電図(ECG)
  • 血液検査
  • 胸部X線
  • HIV抗体検査
  • B型肝炎コア抗体検査
  • 抗HCV抗体検査
  • 心エコー図検査
  • 全血球計算(CBC)
  • 生化学血液検査
  • PET/CT
  • 免疫専門医への相談
  • 循環器科医への相談
  • 小児血液専門医との相談
  • 小児科医との相談
  • 腫瘍血液専門医との診察
  • 頭部MRI
  • 生検
  • 腫瘍マーカーおよび蛋白分画を含む全血球算定
期間
  • 30 日 病院で
宿泊

入院

交通
  • 空港-クリニック-空港間の送迎

追加情報

Bone Marrow Transplant for Pediatric Hodgkin Lymphoma

Sheba Medical Center – Advanced, Personalized Transplant Care for Children

At Sheba Medical Center, we understand that a diagnosis of Hodgkin Lymphoma (HL) in a child or adolescent is a deeply emotional experience for the entire family.

While most children with Hodgkin Lymphoma respond well to standard treatments such as chemotherapy and radiotherapy, a small number may require more advanced therapy. In these cases, bone marrow transplantation (BMT) may offer a highly effective and potentially curative option.

Our pediatric transplant program combines global expertise, advanced medical technology, and a compassionate, family-centered approach to support children at every stage of their treatment journey.

When is a Bone Marrow Transplant Needed?

In pediatric Hodgkin Lymphoma, a bone marrow transplant may be considered when:

The disease returns after initial treatment (relapsed HL)
The lymphoma does not respond adequately to standard therapies (refractory HL)
More intensive treatment is needed to achieve long-term remission

The goal of BMT is to allow the use of very high-dose therapy to eliminate lymphoma cells, followed by the restoration of healthy blood-forming cells, helping the child’s immune system recover and remain strong.

Types of Transplant

At Sheba, treatment is carefully tailored to each child’s condition:

Autologous Transplant (Child’s Own Cells)

This is the most common approach for pediatric Hodgkin Lymphoma. The child’s own stem cells are collected, preserved, and reinfused after high-dose chemotherapy to restore bone marrow function.

Allogeneic Transplant (Donor Cells)

Used only in selected high-risk or difficult cases, this approach uses stem cells from a donor to rebuild the immune system. It is reserved for specific situations where additional immune support is needed.

Finding the Right Donor

In most pediatric HL cases requiring transplant, autologous transplantation is used. When a donor transplant is needed, Sheba ensures access to the best possible match:

Matched family donors when available
Matched unrelated donors through international registries
Haploidentical (half-matched) family donors
Cord blood units

Advanced laboratory technology enables precise matching to ensure safety and the best possible outcomes.

Specialized Pediatric Transplant Care

Children undergoing bone marrow transplantation at Sheba are treated in dedicated pediatric transplant units designed specifically for young patients and their families.

Care includes:

Highly protected, child-friendly hospital environments
Advanced infection prevention systems
Pediatric-specific chemotherapy and transplant protocols
Continuous monitoring by experienced pediatric oncology and transplant teams

Every aspect of care is adapted to the physical and emotional needs of children.

Clinical Expertise in Pediatric Hodgkin Lymphoma

Sheba Medical Center is a leading center for pediatric hematologic malignancies, offering:

Extensive experience in treating relapsed and refractory Hodgkin Lymphoma
High success rates with autologous stem cell transplantation
Advanced supportive care improving safety and recovery
Long-term follow-up focused on growth, development, and quality of life

Our approach is continuously refined based on the latest international research and clinical advances.

Care That Supports the Whole Family

We recognize that treating a child means caring for the entire family.

At Sheba, families are supported by a multidisciplinary pediatric team including oncologists, transplant specialists, nurses, psychologists, and social workers.

From diagnosis through treatment and recovery, families receive clear communication, emotional support, and continuous guidance.

Why Families Choose Sheba for Pediatric BMT
Leading center for pediatric transplantation in lymphoma
Strong expertise in relapsed and refractory Hodgkin Lymphoma
High success rates with autologous transplantation
Advanced, child-specific transplant protocols
Safe, supportive, family-centered care environment
Full international patient coordination services
A Message of Hope

At Sheba Medical Center, we combine advanced medical care with deep compassion for children and families. Even in more complex cases of Hodgkin Lymphoma, our goal is to provide the highest chance of cure while ensuring every child is cared for with dignity, safety, and hope throughout their journey.

24時間年中無休Bookimedサポート
  • 専任医療コーディネーター
  • 医療旅行手配 — 特別パートナー価格での航空券・ホテル予約
  • 医療旅行中の患者擁護

プログラム料金

$160,000

このパッケージに含まれないもの

航空運賃
ホテル
含まれない追加活動

医師

Amos Toren
Hematologist/oncologist
43年の経験
委員会認定プロフェッショナル

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

続きを読む
医師プロフィールを見る

調子はいかがですか?

1 の 3
このプログラムの情報は完全で明確です
1
2
3
4
5
強く反対
強く賛成

クリニックについて

すべての写真を表示
シェバ医療センター

シェバ医療センターはイスラエルおよび世界有数の病院の一つです。 ニューズウィーク・インターナショナル誌は、Sheba Hospitalを2020年の世界トップ10病院にランク付けしました。同病院は1,990の専門分野をカバーしており、毎年世界中から1,500,000人を超える患者がシェバ病院を受診しています。

支払い・特典

当社サービスへのお支払いはありません

クリニックで直接またはその公式銀行口座にお支払いいただきます。

安全な予約

一部のクリニックでは保証金が必要な場合があります。

柔軟な分割払い

分割払いオプションでお支払いを分散してください。

紹介プログラム

Bookimedにお友達を紹介して報酬を獲得してください。

所在地
Derech Sheba 2, Ramat Gan, Israel

なぜ皆様に愛されるのか

こちらもお気に入りかもしれません

$160,000
パッケージあたり
5.0
2 レビュー